Data on the endogenous conversion of tyrosolinto hydroxytyrosol in humans
Rights accessOpen Access
All rights reserved. This work is protected by the corresponding intellectual and industrial property rights. Without prejudice to any existing legal exemptions, reproduction, distribution, public communication or transformation of this work are prohibited without permission of the copyright holder
Here we present new and original data on the endogenous con-version of tyrosol (Tyr) into hydroxytyrosol (OHTyr) in humans and its effects on the cardiovascular system. A randomized,crossover, controlled clinical trial was performed with individuals at cardiovascular risk (n¼33). They received white wine (WW)(females 1, males 2 standard drinks/day), WW plus Tyr capsules(WWþTyr) (25mg Tyr capsule, one per WW drink), and water(control)ad libitum. Intervention periods were of 4 weeks pre-ceded by three-week wash-out periods. We assessed the conversion of Tyr to OHTyr, its interaction with a polygenic activity score(PAS) fromCYP2A6andCYP2D6genotypes, and the effects on cardiovascular risk markers. For further details and experimental findings please refer to the article“Cardiovascular benefits of tyrosol and its endogenous conversion into hydroxytyrosol Inhumans. A randomized, controlled trial”
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
CitationBoronat, A. [et al.]. Data on the endogenous conversion of tyrosolinto hydroxytyrosol in humans. "Data in brief", Desembre 2019, vol. 27, p. 104787:1-104787:12.